People · Operator
Named in public records as an officer, director or promoter · active 2010–2024 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Clearmind Medicine Inc. | — | Biotechnology | Seed | $2.4M | $15.1M | 2024 |
| 0824239 B.C. Ltd. | — | Other | Seed | $1.3M | $24.3M | 2010 |
Alan Rootenberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Alan Rootenberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Amitay Weiss | 1 | 6 |
| Oz Adler | 1 | 4 |
| Asaf Itzhaik | 1 | 2 |
| Yehonatan Shachar | 1 | 2 |
| Dr. Adi Zuloff-Shani | 1 | 2 |
| Prof. Mark Haden | 1 | 1 |
| Bongani Mtshisi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.